How one Israeli company is changing the world of cancer treatment
Biotech company NeoTXis' Tumor Targeted Superantigen (TTS) technology works to kill cancer cells in a way that no other available cancer treatment can.
Two genetically engineered T Cells (light green) attacking a cancer cell in red.(photo credit: TILDA BARLIYA/ASTAR SHAMUL/CYRILLE COHEN)BySHIRA SILKOFFUpdated:
